Serial Number | 97695978 |
Word Mark | EDIT-TO-CURE |
Filing Date | Tuesday, November 29, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, May 22, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Our technology is an RNA editing platform that delivers therapies for rare and chronic diseases. We deliver edit-to-cure therapeutics for undruggable target conditions by using RNA-editing to address the root cause of disease progression |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, December 21, 2022 |
Primary Code | 035 |
First Use Anywhere Date | Monday, August 1, 2022 |
First Use In Commerce Date | Monday, August 1, 2022 |
Party Name | EDIRNA, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Germantown, MD 20876 |
Event Date | Event Description |
Friday, September 8, 2023 | ASSIGNED TO EXAMINER |
Tuesday, January 30, 2024 | ASSIGNED TO EXAMINER |
Tuesday, February 6, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, February 6, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, February 6, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 22, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, May 22, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Friday, December 15, 2023 | ASSIGNED TO EXAMINER |
Wednesday, December 21, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |